Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
INOVIO Announces the Appointment of Jacqueline Shea, Ph.D., as Chief Executive Officer
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect […]
Pfizer to Acquire Biohaven Pharmaceuticals
Pfizer Inc. (NYSE: PFE) and Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that the […]
Sphere Fluidics Strengthens Commercial Team With Three New Senior Hires
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, […]
Targovax and Oslo University Hospital Announce Collaboration To Test TG Mutant RAS Vaccination in Multiple Myeloma
Targovax ASA (OSE: TRVX), a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid […]
TheraVet Signs an Important Distribution Agreement With the Orthopaedics & Surgical Instrumentation Distributor, Veterinary Instrumentation
TheraVet (ISIN: BE0974387194 – ticker: ALVET), a pioneering company in the management of osteoarticular diseases […]
seqWell’s plexWell Technology Selected by California Conservation Genomics Project for Conservation Genomics Research
seqWell, a global provider of next-generation sequencing (NGS) library technologies based on its proprietary plexWell™ […]
Bausch Health Announces Thomas J. Appio As Chief Executive Officer
Bausch Health Companies Inc. (NYSE/TSX: BHC) (Bausch Health) today announced its full leadership team and […]
Adaptiiv Collaborates With HP and Varian To Enhance Personalization in Radiation Oncology With 3D Printed Medical Devices
Adaptiiv Medical Technologies Inc. (Adaptiiv) is collaborating with HP Inc. (HP) and Varian, a Siemens […]
InxMed Raised $15 million in Series B+ Financing to Advance Innovative Therapies to Drug-resistant Cancers
InxMed Co., Ltd, a clinical-stage biotechnology company dedicated to developing innovative therapies targeting stroma microenvironment and drug […]
BICO Acquires Allegro 3D, Adding New Light-based 3D Bioprinting Technology – Complementing the Existing Offering of Application Tailored Products
BICO has acquired all the shares in San Diego-based Allegro 3D Inc. (“Allegro 3D”) for […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more